Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-15

Clinical Trial Update: Partial Thromboplastin Time During the First 24 Hours of Antithrombotic Prophylaxis Using Unfractionated Heparin (UFH) [NA]

View source ↗

Summary

This clinical trial update reports on partial thromboplastin time measurements during the first 24 hours of antithrombotic prophylaxis using unfractionated hepa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Thrombosis | NA | Status: COMPLETED